Bristol Cash Flows Other Operating from 2010 to 2025

BMY Stock  USD 59.14  0.09  0.15%   
Bristol Myers Cash Flows Other Operating yearly trend continues to be fairly stable with very little volatility. Cash Flows Other Operating is likely to outpace its year average in 2025. During the period from 2010 to 2025, Bristol Myers Cash Flows Other Operating regression line of annual values had r-squared of  0.06 and arithmetic mean of  185,308,438. View All Fundamentals
 
Cash Flows Other Operating  
First Reported
2010-03-31
Previous Quarter
-1.2 B
Current Value
108 M
Quarterly Volatility
1.8 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.8 B, Interest Expense of 1.4 B or Selling General Administrative of 3.6 B, as well as many indicators such as Price To Sales Ratio of 2.98, Dividend Yield of 0.0374 or PTB Ratio of 6.92. Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
  
Check out the analysis of Bristol Myers Correlation against competitors.

Latest Bristol Myers' Cash Flows Other Operating Growth Pattern

Below is the plot of the Cash Flows Other Operating of Bristol Myers Squibb over the last few years. It is Bristol Myers' Cash Flows Other Operating historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bristol Myers' overall financial position and show how it may be relating to other accounts over time.
Cash Flows Other Operating10 Years Trend
Pretty Stable
   Cash Flows Other Operating   
       Timeline  

Bristol Cash Flows Other Operating Regression Statistics

Arithmetic Mean185,308,438
Geometric Mean605,051,443
Coefficient Of Variation2,172
Mean Deviation1,956,268,672
Median(58,000,000)
Standard Deviation4,025,596,681
Sample Variance16205428.6T
Range21.2B
R-Value0.24
Mean Square Error16371955.6T
R-Squared0.06
Significance0.37
Slope202,005,037
Total Sum of Squares243081429.6T

Bristol Cash Flows Other Operating History

2025-937.4 M
2024-986.7 M
2022-858 M
2021251 M
202013 B
2019572 M
2018-3 M

About Bristol Myers Financial Statements

Bristol Myers investors use historical fundamental indicators, such as Bristol Myers' Cash Flows Other Operating, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bristol Myers. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash Flows Other Operating-986.7 M-937.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.